Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- AdventHealth
- Study ID
- NCT05877885
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Targeted Cognitive Training Intervention — BEHAVIORALIn this intervention, participants will complete 25-30 minutes of cognitive training per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform, and includes tasks that emphasize training of sustained attention, salience detection, and dimensions of cognitive control. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants.
- General Cognitive Training Intervention — BEHAVIORALIn this intervention, participants will complete 25-30 minutes of cognitive activities per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform. The intervention protocol will include computerized cognitive activities designed to provide general cognitive stimulation. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants.
Study Details
The goal of this randomized controlled trial is to evaluate the potential of a customized digital cognitive training intervention to target aspects of brain function in apathy of late-life depression and reduce symptoms of apathy and related cognitive and behavioral deficits. The investigators hypothesize that 4 weeks of a customized digital cognitive training program will lead to changes in brain connectivity, apathy severity, and cognitive control performance.
Key Dates
- Start date
- Sep 19, 2025
- Status verified
- Oct 2025
- Primary completion
- Nov 1, 2028
- Completion
- Dec 1, 2028
Study Design
- Enrollment
- 84 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Targeted Cognitive Training Intervention
- Active Comparator: General Cognitive Training Intervention
Primary Outcome Measure
Change in Resting State Functional Connectivity among the Salience, Executive Control, and Reward Networks [ Time Frame: Baseline and Post-treatment (Week 4) ]
Central Contacts
- Lauren Oberlin, PhD(860) 690-8441
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| AdventHealth Neuroscience Institute | Orlando | Florida | 32804 | Lauren Oberlin, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orlando, FL
By condition
By specialty
By research site
Related Studies
- Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Huntsville, Alabama
- Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative AnalyticsEnrolling By Invitation · Mayo Clinic · Jacksonville, Florida
- Study of ALTO-300 in MDDPHASE2 · Recruiting · Alto Neuroscience · Phoenix, Arizona
- Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic DepressionRecruiting · Florida State University · Tallahassee, Florida